Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly alter » significantly altered (Expand Search), significantly smaller (Expand Search), significantly better (Expand Search)
alter decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
Showing 2,641 - 2,660 results of 21,342 for search '(( significant decrease decrease ) OR ( significantly alter decrease ))', query time: 0.49s Refine Results
  1. 2641
    Timeline of monitoring of exclusive breastfeeding mothers (EBF) and exclusive breastfeeding – donors (EBF+).

    Timeline of monitoring of exclusive breastfeeding mothers (EBF) and exclusive breastfeeding – donors (EBF+). by Larissa Brazolotto Ferreira (17671168)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2642
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2643
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2644
    <i>M</i>. <i>bovis</i> 0690::Tn mutant failed to elicit the recruitment of neutrophils into milk spaces.

    <i>M</i>. <i>bovis</i> 0690::Tn mutant failed to elicit the recruitment of neutrophils into milk spaces. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 2645
    Data supporting the findings of this study.

    Data supporting the findings of this study. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 2646
    Comparison of densitometric, biochemical, and hormonal variables, and bone turnover markers of EBF + 6 months versus EBF + one year postpartum.

    Comparison of densitometric, biochemical, and hormonal variables, and bone turnover markers of EBF + 6 months versus EBF + one year postpartum. by Larissa Brazolotto Ferreira (17671168)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2647
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2648
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2649
    I Optimal design for optimization of Axitinib loaded Spanlastics.

    I Optimal design for optimization of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2650
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2651
    ANOVA for I optimal design of Axitinib loaded Spanlastics.

    ANOVA for I optimal design of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2652
    The kinetic release data of the optimized formula compared to drug suspension.

    The kinetic release data of the optimized formula compared to drug suspension. by Randa Mohammed Zaki (21637175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2653
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2654
    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group.

    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2655
    Oligonucleotides used in this study.

    Oligonucleotides used in this study. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 2656
    Open data.

    Open data. by Larissa Brazolotto Ferreira (17671168)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2657
    Impact of 5′ nucleotidase disruption on <i>M</i>. <i>bovis</i> growth phenotype in axenic conditions.

    Impact of 5′ nucleotidase disruption on <i>M</i>. <i>bovis</i> growth phenotype in axenic conditions. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 2658
    General and sociodemographic characteristics of the EBF and EBF+ groups.

    General and sociodemographic characteristics of the EBF and EBF+ groups. by Larissa Brazolotto Ferreira (17671168)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2659
    Inactivation of MnuA and 5′-NT reduced bacterial fitness and virulence of <i>M</i>. <i>bovis</i> PG45 in mammary glands.

    Inactivation of MnuA and 5′-NT reduced bacterial fitness and virulence of <i>M</i>. <i>bovis</i> PG45 in mammary glands. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 2660
    Mapping of transposon insertions in the selected mutants of <i>M</i>. <i>bovis</i> PG45.

    Mapping of transposon insertions in the selected mutants of <i>M</i>. <i>bovis</i> PG45. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: